Adrenaline junkie? Raising capital could be for you!
January 19, 2017 - Comments Off on Adrenaline junkie? Raising capital could be for you!Raising capital is no easy task and demands a great deal of time and energy. We interviewed Kitozyme CEO François Blondel, who agreed to share his experience of running several campaigns to raise capital. We also talked to KiOmed Pharma, […]
BioWin supports the ‘SMART’ project
December 22, 2016 - Comments Off on BioWin supports the ‘SMART’ projectProviding software that is able to analyse, compare and measure huge amounts of data clinical trials, with the aim of detecting anomalies: this is what the company CluePoints accomplished. CluePoints is the outcome of the BioWin ‘SMART’ (Statistical Monitoring Applied […]
ADHD, a disorder cured by play
December 06, 2016 - Comments Off on ADHD, a disorder cured by playIn 2013, a new BioWin project, NeuroAtt, was launched to enable making a reliable diagnosis for ADHD (Attention Deficit Hyperactivity Disorder) and to find the least invasive treatment for children. Now the project is nearing completion, we heard out Anne-Marie […]
Self-expanding stents to treat the silent killer : aneurysm
July 11, 2016 - Comments Off on Self-expanding stents to treat the silent killer : aneurysmThe continuous flow in jet-induced fountains inspired Nourredine Frid, CEO at Cardiatis (Isnes), to apply the theory of fluid mechanics to blood vessels. By converting turbulence to laminar flow in a blood vessel, an aneurysm (a localized dilation of a […]
Latest Articles
NautaDutilh, a law firm involved in the various development stages of spin-offs conducted a survey entitled “Belgian TTO’s and their spin-offs: a match made [...]
NautaDutilh, a law firm involved in the various development stages of spin-offs conducted a survey entitled “Belgian TTO’s and their spin-offs: a match made [...]
MEDI-LINE and the CHU of Liège have recently launched the Tom-Sling®, a new medical device that allows treating male urinary incontinence that occurs after [...]
ImCyse plans first-in-human-therapy(FIHT) with disease-modifying vaccine to treat multiple sclerosis
Belgian-based ImCyse, a spin-off originally from the Catholic University of Leuven (KUL), but now established at both KUL and University of Liège (ULg), was [...]
Intuitim, Spin-off of UCL discovers potential market in China for specialized medical imaging device
For Intuitum, it all began at UCL in 2012, with a project aimed at developing innovative tools for medical imaging. Intuitim, founded by Vincent [...]
Belgian researcher Denis Dufrane and his team of researchers from the University of St. Luc’s (UCL) Cell and Tissue Therapy Center (CTTC) have developed [...]
Cardio3 BioSciences (C3BS) (Euronext Brussels and Paris: CARD), brings breaking news with yesterday’s recent announcement of a fully committed capital increase of €25M in [...]
Updating on a story from 2012, the spin-off of ULg, Synolyne Pharma has raised € 3,3 million to pursue the development of its [...]
Guest blogger: Anne-Laure Languille A study conducted by the firm M5 closely examined results obtained by BioWin, the health cluster of Wallonia. The [...]
At the recently held conference hosted by OncoDNA in the IPG building (Gosselies, Belgium) Jean-Pol Detiffe (CEO, OncoDNA) and Martine Piccart (Co-founder and chair, [...]
